Fidelity Investments
BBOT

Fidelity Investments’s BridgeBio Oncology BBOT Stock Holding History

Fidelity Investments’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.83M Buy
240,587
+287
+0.1% +$2.4K ﹤0.01% 2783
2026
Q1 		$2.15M Hold
240,300
– – ﹤0.01% 2617
2025
Q4 		$3.01M Buy
240,300
+78,223
+48% +$948K ﹤0.01% 2458
2025
Q3 		$1.88M Buy
+162,077
New +$1.69M ﹤0.01% 2565

Other funds holding BBOT

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments's BBOT Position: Q2 2026 in Review

Fidelity Investments increased its BridgeBio Oncology (BBOT) stake by 0.12% in Q2 2026, buying an estimated $2.4K and bringing the position to 240,587 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #2783.

Fidelity Investments first reported a position in BBOT in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.01M in Q4 2025. 65 funds tracked by Wall St. Rank hold BBOT as of Q2 2026.

  • Fidelity Investments held 240,587 shares of BridgeBio Oncology worth $1.83M as of Q2 2026.
  • Fidelity Investments bought 287 BridgeBio Oncology shares in Q2 2026, an estimated $2.4K.
  • BridgeBio Oncology made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #2783 holding.
  • Fidelity Investments first reported a position in BridgeBio Oncology in Q3 2025 and has held it in 4 quarters since.
  • Fidelity Investments's BridgeBio Oncology position peaked at $3.01M in Q4 2025.
  • 65 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.